Lumida
/JBTM
⌘K
JBT Marel Corp

JBT Marel Corp

JBTM
$134.00USD-3.42%-4.75 today

MARKET CAP

7.0B

P/E (TTM)

19.2x

FWD P/E

14.8x

DAY RANGE

$134 – $139

52W RANGE

$114
$170

AI Summary

Stalk
StalkMedium

JBTM remains in a healthy Stage 2 uptrend with medium- and long-term bullish structure intact, but recent price pullback into the flat-to-declining EMA band and sideways short-term trend suggest timing is unfavorable. We will defer entry and await clear acceptance off the 9/21/50 EMA zone before initiating new exposure.

  • Poultry segment orders rose 12% YoY, pushing intake above $1 billion
  • Merger synergies of $150 million targeted, boosting adjusted EBITDA margin to 17–17.5% by 2026
  • Negative profitability factors raise cost management concerns amid tariff pressures
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

JBT Marel Corporation (NYSE:JBTM) operates in the food processing sector, focusing on automated solutions primarily related to poultry, meat, and prepared food industries. The company has emerged as a formidable player following the merger between JBT and Morrell, benefitting from operational synergies and a broadened product offering. JBTM is currently positioned amidst a recovery in protein demand, with a strong emphasis on automation and efficiency — key components in the ongoing shift toward advanced manufacturing technologies within the industry.

Bull says

  • Poultry segment orders rose 12% YoY, pushing intake above $1 billion
  • Merger synergies of $150 million targeted, boosting adjusted EBITDA margin to 17–17.5% by 2026
  • Generated $100 million FCF with 70% conversion rate, underpinning financial resilience
  • Guided 5–7% organic revenue growth through 2026 on sustained protein demand
  • Authorized $200 million share repurchase to enhance shareholder returns
  • Favorable valuation shows strong earnings yield, solid book-to-price and low leverage

Bear says

  • Negative profitability factors raise cost management concerns amid tariff pressures
  • Underperformance in momentum factors points to near-term share-price pressure
  • Annualized tariff costs of $50–60 million (with $22–25 million direct margin impact)
  • High short interest reflects market skepticism and potential volatility
  • Heavy reliance on poultry cycle exposes vulnerability to demand shifts
  • Lack of dividend yield and weak ownership metrics may deter investors

Investment themes with JBTM

Robotics +0.20%

Robotics and automation technology companies

JBTM · SMCAY · AZTA

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 06-14-2026neutral

Transcript signals

Bull points

  • We ended the year with extremely strong orders in the fourth quarter, up 25% year over year and 19% sequentially.
  • JBT's full year revenue increased 3%, or about 3.5% organically, excluding the impact of foreign exchange.
  • Adjusted EBITDA of 295 million increased 8%.

Bear points

  • our results came in at the lower end of our guidance due to a mix of lower than expected volume on quick turn book and ship revenue and some delayed equipment shipments.
  • On the expense side, we had higher than expected employee health care costs.
  • Model's full-year revenue of 1.64 billion euros declined 4.6% compared to the prior year due to lower project revenues.
Read full transcript analysis ›